1. Home
  2. TCRX vs OSS Comparison

TCRX vs OSS Comparison

Compare TCRX & OSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCRX
  • OSS
  • Stock Information
  • Founded
  • TCRX 2018
  • OSS 1998
  • Country
  • TCRX United States
  • OSS United States
  • Employees
  • TCRX N/A
  • OSS N/A
  • Industry
  • TCRX Biotechnology: Pharmaceutical Preparations
  • OSS Computer Manufacturing
  • Sector
  • TCRX Health Care
  • OSS Technology
  • Exchange
  • TCRX Nasdaq
  • OSS Nasdaq
  • Market Cap
  • TCRX 91.7M
  • OSS 106.4M
  • IPO Year
  • TCRX 2021
  • OSS 2018
  • Fundamental
  • Price
  • TCRX $1.91
  • OSS $5.73
  • Analyst Decision
  • TCRX Strong Buy
  • OSS
  • Analyst Count
  • TCRX 5
  • OSS 0
  • Target Price
  • TCRX $9.40
  • OSS N/A
  • AVG Volume (30 Days)
  • TCRX 208.8K
  • OSS 618.8K
  • Earning Date
  • TCRX 08-12-2025
  • OSS 11-05-2025
  • Dividend Yield
  • TCRX N/A
  • OSS N/A
  • EPS Growth
  • TCRX N/A
  • OSS N/A
  • EPS
  • TCRX N/A
  • OSS N/A
  • Revenue
  • TCRX $6,961,000.00
  • OSS $55,208,915.00
  • Revenue This Year
  • TCRX $255.18
  • OSS $11.62
  • Revenue Next Year
  • TCRX N/A
  • OSS $12.81
  • P/E Ratio
  • TCRX N/A
  • OSS N/A
  • Revenue Growth
  • TCRX N/A
  • OSS 4.65
  • 52 Week Low
  • TCRX $1.02
  • OSS $1.85
  • 52 Week High
  • TCRX $6.23
  • OSS $6.60
  • Technical
  • Relative Strength Index (RSI)
  • TCRX 59.09
  • OSS 53.95
  • Support Level
  • TCRX $1.73
  • OSS $4.76
  • Resistance Level
  • TCRX $1.95
  • OSS $6.60
  • Average True Range (ATR)
  • TCRX 0.12
  • OSS 0.43
  • MACD
  • TCRX 0.01
  • OSS -0.03
  • Stochastic Oscillator
  • TCRX 84.85
  • OSS 52.72

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

About OSS One Stop Systems Inc.

One Stop Systems Inc designs, manufactures, and markets specialized rugged high-performance compute ("HPC"), high-speed switch fabrics, and storage systems, which are designed to target edge applications for artificial intelligence ("AI") / machine learning ("ML"), sensor processing, sensor fusion, and autonomy. The company operates in two reportable segments; OSS designs and manufactures high-performance customized computers and flash arrays, in-flight entertainment & connectivity. Bressner operates as a system integrator with standard and custom all-in-one hardware systems and components for many kinds of industrial environments. The company generates the majority of its revenue from the Bressner segment.

Share on Social Networks: